全文获取类型
收费全文 | 8004篇 |
免费 | 646篇 |
国内免费 | 66篇 |
专业分类
耳鼻咽喉 | 69篇 |
儿科学 | 185篇 |
妇产科学 | 216篇 |
基础医学 | 1039篇 |
口腔科学 | 155篇 |
临床医学 | 698篇 |
内科学 | 2005篇 |
皮肤病学 | 110篇 |
神经病学 | 589篇 |
特种医学 | 196篇 |
外科学 | 1380篇 |
综合类 | 145篇 |
一般理论 | 9篇 |
预防医学 | 541篇 |
眼科学 | 181篇 |
药学 | 581篇 |
中国医学 | 70篇 |
肿瘤学 | 547篇 |
出版年
2023年 | 69篇 |
2022年 | 81篇 |
2021年 | 183篇 |
2020年 | 139篇 |
2019年 | 168篇 |
2018年 | 207篇 |
2017年 | 150篇 |
2016年 | 194篇 |
2015年 | 207篇 |
2014年 | 310篇 |
2013年 | 344篇 |
2012年 | 546篇 |
2011年 | 507篇 |
2010年 | 310篇 |
2009年 | 281篇 |
2008年 | 436篇 |
2007年 | 425篇 |
2006年 | 449篇 |
2005年 | 412篇 |
2004年 | 429篇 |
2003年 | 378篇 |
2002年 | 379篇 |
2001年 | 245篇 |
2000年 | 202篇 |
1999年 | 216篇 |
1998年 | 73篇 |
1997年 | 69篇 |
1996年 | 44篇 |
1995年 | 47篇 |
1994年 | 43篇 |
1993年 | 26篇 |
1992年 | 101篇 |
1991年 | 141篇 |
1990年 | 86篇 |
1989年 | 64篇 |
1988年 | 58篇 |
1987年 | 53篇 |
1986年 | 54篇 |
1985年 | 58篇 |
1984年 | 37篇 |
1983年 | 34篇 |
1982年 | 26篇 |
1979年 | 36篇 |
1978年 | 28篇 |
1977年 | 25篇 |
1976年 | 24篇 |
1974年 | 37篇 |
1973年 | 30篇 |
1972年 | 28篇 |
1971年 | 28篇 |
排序方式: 共有8716条查询结果,搜索用时 0 毫秒
41.
Seong‐II BIN Shing‐Sheng WU Xiaofeng ZENG Alan MOORE Nicole FRANK 《International journal of rheumatic diseases》2007,10(3):190-197
Aim: The aim of the current study was to assess the efficacy, safety, and tolerability of lumiracoxib 200 mg once daily (o.d.) in relieving osteoarthritis (OA) knee pain in patients in China, Taiwan, and South Korea. Methods: Patients of either sex (aged ≥ 18 years) with symptomatic, primary OA of the knee for ≥ 3 months were eligible for inclusion if they had OA pain intensity of ≥ 40 mm (100 mm visual analogue scale [VAS]) in the target knee joint during the previous 24 h. Patients were required to undergo regular non‐steroidal anti‐inflammatory drug therapy for ≥ 6 weeks. After 3–7 days of screening, patients were randomized (1 : 1) to receive either lumiracoxib 200 mg o.d. or celecoxib 200 mg o.d. The primary efficacy comparison between the study groups was overall OA pain intensity (VAS) in the target knee after 6 weeks of treatment. Results: The mean overall OA pain intensity (VAS) in the target knee after 6 weeks decreased from 60.6 mm to 35.7 mm and 60.5 mm to 36.1 mm in the lumiracoxib and celecoxib groups, respectively. Both study groups showed similar results in terms of improvement in both patient's and physician's global assessment of disease activity and functional health status. The percentage of adverse events (AEs) in the lumiracoxib and celecoxib groups (40.3% and 37.9%, respectively) was similar, as was the proportion of treatment‐related AEs (21.0% and 18.2%, respectively). Conclusions: Lumiracoxib 200 mg o.d. provided effective and well‐tolerated pain relief similar to that achieved with celecoxib 200 mg o.d. in knee OA patients. 相似文献
42.
John Fung Dympna Kelly Zakiyah Kadry Kusum Patel-Tom Bijan Eghtesad 《Liver transplantation》2005,11(3):267-280
Although calcineurin inhibitors (CNIs) remain the mainstay of immunosuppression in liver transplantation (LTX), their long-term toxicity significantly contributes to morbidity and mortality. The elucidation of mechanisms of alloimmunity and leukocyte migration have provided novel targets for immunosuppression development. The toxicities of these agents differ from that of the CNI and act additively or synergistically. CNI avoidance protocols in LTX have not been achieved routinely; however, pilot trials have begun to delineate the limitations and promises of such approaches. CNI-sparing protocols appear to be much more promising in balancing the early need for minimizing rejection while tapering doses and minimizing long-term toxicity. 相似文献
43.
Levels of cardiovascular risk factors were determined in 75 patients with Type 2 diabetes mellitus. The patients were divided into three groups according to their urinary protein excretion (UPE): (a) normal proteinuria (less than or equal to 70 mg d-1); (b) microproteinuria (70-500 mg d-1); and (c) macroproteinuria (greater than 500 mg d-1). A significant stepwise increase in mean systolic blood pressure, LDL-cholesterol and fibrinogen levels was observed from the first to the third investigated group of patients. Mean apoprotein B levels were significantly increased in the group with macroproteinuria compared to the other two groups. Significant linear correlations were found between UPE and LDL-cholesterol, total cholesterol, apoprotein B, creatinine, systolic blood pressure and diabetes duration. In summary, it is concluded that the levels of some cardiovascular risk factors increase with the stage of proteinuria in Type 2 diabetes mellitus. 相似文献
44.
45.
Hydrophobic effects could play an important role in determining the selectivity of organic ions for ion-exchange resins in aqueous solutions. We used the octanol-water partition coefficient (P) and the chromatographic capacity factor (K') as indices of hydrophobicity of a series of primary and secondary amines, and examined their relationships with the amine selectivity coefficient (K) in binding to the Amberlite IRP-69 ion-exchange resin. Good correlations were found between log K versus log P and log K versus log K', but the relationship appears to be dependent on the degree of substitution at the amino nitrogen. These relationships may be useful for the estimation of selectivity coefficients of various amine drug candidates when they are considered for incorporation with ion-exchange resins in potential controlled-release systems. 相似文献
46.
S A Boyd A K Fung W R Baker R A Mantei Y L Armiger H H Stein J Cohen D A Egan J L Barlow V Klinghofer 《Journal of medicinal chemistry》1992,35(10):1735-1746
We describe the development of a series of soluble, potent, and bioavailable nonpeptide renin inhibitors. These inhibitors derived from a series of novel nonpeptide renin inhibitors which were recently identified in our laboratories, by alteration of the nature of the C-terminus (P2') of the molecules. Introduction of basic substituents into modified hydroxyethylene dipeptide isosteres gave inhibitors with improved solubility as well as improved potency against human plasma renin. In addition, these modifications produced inhibitors which displayed markedly improved intraduodenal bioavailability in both the ferret and cynomolgus monkey. We also present data which demonstrate excellent efficacy in the monkey for A-74273 (65), with an intraduodenal bioavailability of 16 +/- 4% in the monkey, compared to 1.7 +/- 0.5% for the dipeptide renin inhibitor enalkiren (A-64662, 75). A-74273 is an example of a nonpeptide inhibitor which possesses a good balance of the desirable properties of potency, solubility, and lipophilicity and which is well absorbed into the intestine. 相似文献
47.
H Furukawa O Imventarza R Venkataramanan M Suzuki Y Zhu V S Warty J Fung S Todo T E Starzl 《Transplantation》1992,53(4):722-725
Mongrel or beagle dogs were submitted to bile duct ligation, or to extraenteric biliary diversion by means of choledochoureterostomy. The kinetics of intravenously administered FK506 was not changed from control status two weeks after bile duct ligation, but the bioavailability of orally administered FK506 was nearly quadrupled. Following oral administration, the absorption of FK506 was highly variable. The results indicate that in dogs FK506 is absorbed from the intestine just as efficiently in the absence of enteric bile and in presence of exogenous bile salt supplement when compared with its absorption in presence of normal bile drainage. These findings with FK506 are different from those with cyclosporine after biliary obstruction or diversion and will have important practical as well as experimental ramifications. 相似文献
48.
B. J. Nankivell M. D. Wavamunno R. J. Borrows M. Vitalone C. L-S Fung R. D. M. Allen J. R. Chapman P. J. O'Connell 《American journal of transplantation》2007,7(2):366-376
Mycophenolate mofetil (MMF) reduces acute rejection in controlled trials of kidney transplantation and is associated with better registry graft survival. Recent experimental studies have demonstrated additional antifibrotic properties of MMF, however, human histological data are lacking. We evaluated sequential prospective protocol kidney biopsies from two historical cohorts treated with cyclosporine (CSA)-based triple therapy including prednisolone and either MMF (n = 25) or azathioprine (AZA, n = 25). Biopsies (n = 360) were taken from euglycemic kidney-pancreas transplant recipients. Histology was independently assessed by the Banff schema and electron microscopic morphometry. MMF reduced acute rejection and OKT3 use (p < 0.05) compared with AZA. MMF therapy was associated with limited chronic interstitial fibrosis, striped fibrosis and periglomerular fibrosis (p < 0.05-0.001), mesangial matrix accumulation (p < 0.01), chronic glomerulopathy scores (p < 0.05) and glomerulosclerosis (p < 0.05). MMF was associated with delayed expression of CSA nephrotoxicity, reduced arteriolar hyalinosis, striped fibrosis and tubular microcalcification (p < 0.05-0.001). The beneficial effects of MMF remained in recipients without acute rejection. Retrospective analysis shows that MMF therapy was associated with substantially reduced fibrosis in the glomerular, microvascular and interstitial compartments, and a delayed expression of CSA nephrotoxicity. These outcomes may be due to a limitation of immune-mediated injury and suggest a direct effect of reduced fibrogenesis. 相似文献
49.
50.
Y K Fung 《The Journal of pharmacy and pharmacology》1990,42(8):595-596
Bilateral injections of either nicotine (200 micrograms) or cytisine (30 or 60 micrograms) into the nucleus accumbens elicited locomotor hyperactivity in rats. Pretreatment with mecamylamine (2 mg kg-1, s.c.) was effective in attenuating the stimulatory effect of either nicotine or cytisine. This study suggests that nicotinic agonists such as nicotine and cytisine produce their locomotor excitatory effects through stimulation of the mesolimbic dopaminergic pathway. 相似文献